» Articles » PMID: 35548052

Transcriptomic Profiles of Splenic CD19 B Cells in Mice Chronically Infected With the Larval

Overview
Journal Front Vet Sci
Date 2022 May 13
PMID 35548052
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We previously reported that the larval () infection can expand the population of regulatory B cells in mice, thereby inhibiting the anti-infective immunity. However, the underlying mechanism is still largely unknown. This study further investigated the holistic transcriptomic profiles of total splenic B cells following the chronic infection of the parasite.

Methods: The infection model of larval was established by intraperitoneal inoculation with 2000 protoscolexes. Magnetic-Activated Cell Separation (MACS) was used to isolate the total splenic B cells. RNA sequencing was performed to screen the differentially expressed genes (DEGs) after infection. The expression of selected DEGs was verified using qRT-PCR. Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Co-expression network analysis were applied to predict these DEGs' underlying biological processes, pathways, and interactions respectively.

Results: A total of 413 DEGs were identified in larval infected B cells, including 303 up- and 110 down-regulated genes. Notably, most DEGs related to inflammation and chemotaxis were significantly upregulated after infection. In line with these changes, significant expression upregulation of DEGs associated with fatty acid oxidation, lipid synthesis, lipolysis, lipid transport, and cholesterol biosynthesis, were observed in infected B cells. Co-expression network analysis showed an intimate interaction between these DEGs associated with immune and metabolism.

Conclusions: The present study revealed that the larval infection induces metabolic reprogramming of B cells, which provides a novel clue to clarify the immunoregulatory mechanism of B cells in parasitic infection.

Citing Articles

The non-oral infection of larval induces immune and metabolic reprogramming in the colon of mice.

Zhou Y, Luo T, Gong Y, Guo Y, Wang D, Gao Z Front Immunol. 2023; 13:1084203.

PMID: 36713407 PMC: 9880436. DOI: 10.3389/fimmu.2022.1084203.

References
1.
Samavati L, Rastogi R, Du W, Huttemann M, Fite A, Franchi L . STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol. 2009; 46(8-9):1867-77. DOI: 10.1016/j.molimm.2009.02.018. View

2.
Gao Q, Liang X, Shaikh A, Zang J, Xu W, Zhang Y . JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases. Curr Drug Targets. 2016; 19(5):487-500. DOI: 10.2174/1389450117666161207163054. View

3.
Hauffe R, Stein V, Chudoba C, Flore T, Rath M, Ritter K . GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity. JCI Insight. 2020; 5(11). PMC: 7308064. DOI: 10.1172/jci.insight.136283. View

4.
Cabral S, Silvestre R, Santarem N, Tavares J, Silva A, Cordeiro-da-Silva A . A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin. Immunology. 2007; 123(4):555-65. PMC: 2433312. DOI: 10.1111/j.1365-2567.2007.02725.x. View

5.
Abdelrasoul H, Werner M, Setz C, Okkenhaug K, Jumaa H . PI3K induces B-cell development and regulates B cell identity. Sci Rep. 2018; 8(1):1327. PMC: 5778048. DOI: 10.1038/s41598-018-19460-5. View